Argus Research Downgrades Boston Scientific to Hold

Benzinga Newsdesk www.benzinga.com Negative 90.8%

Neg 90.8% Neu 0% Pos 0%

Argus Research analyst David Toung downgrades Boston Scientific (NYSE:BSX) from Buy to Hold.

Comments

No comments yet. Be the first!